About Us关于我们
- Genesis obtained the registration certification of RSV /ADV Antigen Rapid test kits
- Geneis participate in AACC meeting at Chicago
- Genesis participate in the 63rd China International Medical Equipment Fair(CMEF 2010 Spring)
- Genesis participate American Association of Clinical Chemistry's (AACC)
- Exhibition Information 2013
- Geneis participate in Düsseldorf Messe MEDICA – International Trade Fair & Congress for Medicine
- GENESIS Launched Mycoplasma Pneumoniae
Antigen Rapid Diagnostic Test Kit - Genesis’ Sales & Marketing Center was launched
- Paper: Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay
- Overview of Influenza Surveillance in China
- Collection of Technical Documents for Chinese National Influenza Center
- Infectivity, Transmission, and Pathology of Human-Isolated H7N9 Influenza Virus in Ferrets and Pigs
- China's new WHO flu monitoring center seeks to reverse criticism
- No child should die of TB.
- Tuberculosis is a global pandemic
- XDR-TB has been confirmed in more than 100 countries around the world
- Efforts to contain the spread of the tenacious form of TB have proven insufficient, and HIV clinics and hospitals have become the most likely source of infectio
-
2018-12-25
GENESIS completes the innovation technology upgrading project. The second phase expansion project plan is started.
-
2016-05-16
SFDA: Mycoplasma Pneumoniae Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate, No. S20163400806.
-
2015-04-09
Genesis' R& D Center was launched in the Economic and Technological Development Zone, is mainly responsible for Genesis health products of IVD.
-
2015-02-28
Genesis' Marketing Center is responsible for Kaibili brand in the domestic market sales, to promote"product + service" business model and improve the market.
-
2014-12-08
Genesis' Postdoctoral Station was approved by the Hangzhou economic and Technological Development Zone.
-
2014-09-29
After assessment, publicity, approval process, GENESIS was awarded "National High-Tech Pharmaceutical Enterprises" certificate.
-
2014-09-17
Production range changed into Categories Two 6840 clinical detection and analysis instruments; Categories Three in vitro diagnostic reagents * * *.
-
2014-08-13
SFDA: Adenovirus Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate,No.3401509.
-
2014-06-16
Shangyu Changda plastic products Co., Ltd. upgraded to the Shaoxing Chuangda Medical Devices Co., Ltd.
-
2014-01-27
SFDA: RSV Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate, No. S3400267.
-
2013-01-05
Anniversary Ten-Year Celebrations. Colorful programs: Arts Festival; Long service award; Best Newcomer Award; Best Teamwork Award; Advanced employees Awards as
-
2012-12-01
The company's major shareholders changed. Now, GENESIS is a joint-venture of US and Chinese Companies of Diagnostic products.
-
2011-10-17
SFDA: Flu A+B Virus Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate,No.3401262.
-
2009-05-08
May 8, 2009, China famous immune biochemistry expert, academician of the Chinese Academy of Engineering, Shen Bei Fen academician of Academy of Military Medical
-
2008-07-21
The production range was changed into second, three class 6840 in vitro diagnostic reagents.
-
2007-01-08
Shangyu Chang Da plastic products Co., Ltd. was established, and has become the strategic partner of GENESIS.
-
2005-09-07
SFDA: Mycobacterium Tuberculosis Rapid Test Device Kit (Colloidal Gold) Medical Device Registration Certificate, No. SS20050073.
-
2005-03-23
SFDA: Flu A Virus Antigen Raipd Test Device Kit (Colloidal Gold) Medical Device Registration Certificate,No.S20050019.
-
2005-01-23
ISO9001:2000 Certificate
ISO13485:2003 Certificate -
2004-09-03
Approved by the food and Drug Administration of Zhejiang Province, the company obtained a license for medical device manufacturers (second kinds of IVD ).
-
2002-11-01
GENESIS was established in 2002 and registered in the Hangzhou Economic & Technology Development Zone .